Recent Company News

• 04:16 AM ET Sep 17, 2026
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 08:57 AM ET Sep 17, 2026
  

  Transcript Intelligence: Innate Pharma Q2 Earnings Guidance

• 08:57 AM ET Sep 17, 2026
  

  Transcript Intelligence: Innate Pharma Q2 Earnings Themes

• 08:57 AM ET Sep 17, 2026
  

  Transcript Intelligence: Innate Pharma Q2 Earnings Q&A

• 01:13 AM ET Sep 17, 2026
  

  Innate Pharma reports H1 net loss (€19.3M) vs FactSet (€21.8M) [1 est] (€1.56, 0.00)

• 11:28 PM ET Sep 16, 2026
  

  Sobi and Innate announce partnership is now effective following completion of closing conditions

• 04:02 PM ET Sep 16, 2026
  

  Innate Pharma and Sobi announce partnership is now effective following completion of closing conditions (€1.56, 0.00)

• 05:11 PM ET Sep 14, 2026
  

  Transcript Intelligence: Innate Pharma at H.C. Wainwright Global Investment Conference

• 10:36 AM ET Sep 10, 2026
  

  FTC grants antitrust clearance for transaction involving Swedish Orphan Biovitrum and Innate Pharma (SEK 441.60, -1.60)